More evidence of a decrease in the dose of riboxiplab in advanced breast cancer

(MedPage Today)-A lower dose of the CDK4/6 inhibitors of the Kisqali toxic (Kisqali) was able to effectively affect women with hormone receptors (HR)-negative breast cancer/Her2, according to the results of two studies. phase …